If you have primary mediastinal B-cell lymphoma (PMBL), you’ve likely heard about CAR T gene therapy. There’s good reason for that. Loretta Nastoupil, MD, will tell you, “It’s just the most exciting ...
PURPOSE: Primary mediastinal B-cell lymphoma (PMBL) is recognized as a separate disease entity in the REAL classification. There is uncertainty about the relevance and especially the optimal ...
CELESTIMO: A phase III trial evaluating the efficacy and safety of mosunetuzumab plus lenalidomide versus rituximab plus lenalidomide in patients with relapsed or refractory follicular lymphoma who ...
We identified a total of 44 PMBL patients treated with HDT/ASCT after first relapse or primary refractory disease between 1996 and 2012, and retrospectively analyzed. Patient characteristics are ...
Even though it’s one of the latest and greatest cancer treatments, CAR T therapy still has its side effects. They’re often mild, but they can be serious and affect your heart, kidneys, and brain. That ...
This study looked at tissue samples and PET scans to learn more about ‘primary mediastinal diffuse large B cell lymphoma’ (PMBL) and the best way to treat it. Cancer Research UK supported this study.
Please provide your email address to receive an email when new articles are posted on . Nivolumab in combination with brentuximab vedotin appeared safe and induced high antitumor activity among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results